EYEG - EyeGate Pharmaceuticals, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 510.23M
Enterprise Value 35.88M
Trailing P/E N/A
Forward P/E 1-0.97
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)3.41
Price/Book (mrq)1.21
Enterprise Value/Revenue 31.96
Enterprise Value/EBITDA 6-0.88

Trading Information

Stock Price History

Beta (3Y Monthly) 2.03
52-Week Change 3-33.52%
S&P500 52-Week Change 32.99%
52 Week High 39.6000
52 Week Low 32.2500
50-Day Moving Average 32.9906
200-Day Moving Average 33.9722

Share Statistics

Avg Vol (3 month) 324.05k
Avg Vol (10 day) 361.08k
Shares Outstanding 545.68M
Float 1.26M
% Held by Insiders 114.57%
% Held by Institutions 149.43%
Shares Short (Aug 15, 2019) 45.1k
Short Ratio (Aug 15, 2019) 40.32
Short % of Float (Aug 15, 2019) 40.32%
Short % of Shares Outstanding (Aug 15, 2019) 40.17%
Shares Short (prior month Jul 15, 2019) 415.45k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 215/1
Last Split Date 3Aug 30, 2019

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin -220.57%
Operating Margin (ttm)-223.58%

Management Effectiveness

Return on Assets (ttm)-27.99%
Return on Equity (ttm)-60.11%

Income Statement

Revenue (ttm)3M
Revenue Per Share (ttm)1.03
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)-6.4M
EBITDA -6.66M
Net Income Avi to Common (ttm)-6.62M
Diluted EPS (ttm)-2.2740
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)4.47M
Total Cash Per Share (mrq)1.47
Total Debt (mrq)111.08k
Total Debt/Equity (mrq)1.31
Current Ratio (mrq)5.43
Book Value Per Share (mrq)2.78

Cash Flow Statement

Operating Cash Flow (ttm)-8.35M
Levered Free Cash Flow (ttm)-6.59M